-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BhI1j5bHrxg7FX5ks+ejQlbSSjJ/rec/a9MeQDjmoFU130hBHmbqb7QoxjZ3qZhy 5tInlSWe/vlYcsljF7q94Q== 0000812796-97-000003.txt : 19970221 0000812796-97-000003.hdr.sgml : 19970221 ACCESSION NUMBER: 0000812796-97-000003 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970131 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 19970210 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOREX CORP CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 97521590 BUSINESS ADDRESS: STREET 1: 3233 15TH STREET SOUTH CITY: FARGO STATE: ND ZIP: 58104 BUSINESS PHONE: 7012329575 MAIL ADDRESS: STREET 1: 3233 15TH STREET SOUTH CITY: FARGO STATE: ND ZIP: 58104 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 8-K/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 28, 1997 ----------------------------------------------------------------- Endorex Corp. ------------------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE ---------------------------------------------- (State or other jurisdiction of incorporation) 0-11572 41-1505029 -------------------------------------------------------------- (Commission File Number) (IRS Employer Identification No.) 3233 15th Street South, Fargo, North Dakota 58104 ---------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (701) 232-9575 -------------- --------------------------------------------------------------------- (Former name or former address, if changed since last report) ITEM 4. Change in Registrant's Certifying Accountants (a) (i) The Registrant's independent public accountants, Moore Stephens, P.C. ("MS"), were dismissed on January 20, 1997. (ii) MS's report on the financial statements for either of the past two years did not contain an adverse opinion or disclaimer of opinion and was not modified as to uncertainty, audit scope or accounting principles. (iii) The decision to change accountants was approved by the Board of Directors of the Registrant on January 7, 1997. (iV) There were no disagreements or reportable events with MS, whether or not resolved, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to MS's satisfaction, would have caused it to make reference to the subject matter of the disagreements in connection with its reports. (b) (i) Coopers and Lybrand L.L.P. ("C&L") was engaged by the Registrant on January 20, 1997. C&L was not consulted by the Registrant with respect to the application of accounting principles to a specific completed transaction or contemplated transaction, or the type of audit opinion that might be rendered on the Registrant's financial statements. EXHIBIT 16. Letter on change in certifying accountant. MOORE STEPHENS, P.C. January 28, 1996 Securities and Exchange Commissiion 450 Fifth Street, N.W. Washington, D.C. 20549 Gentlemen: We have read the statements made by Endorex Corp., which we understand will be filed with the Commission, pursuant to Item 4 of Form 8-K, as part of the Company's Form 8-K report dated January, 20, 1997. We agree with the statements concerning our Firm in such Form 8-K. Very truly yours, /s/ Moore Stephens, P.C. ------------------------------ Moore Stephens, P.C. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Endorex Corp. (Registrant) By: /s/ Michael S. Rosen -------------------------------- President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----